ReviewJournal of ovarian research2026
Unraveling the mechanisms of PCOS: the interplay between gut microbiota and the immune system.
Review in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut microbiota in PCOS: key microbial changes, potential mechanisms and clinical applications.Journal of translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Polycystic ovary syndrome(PCOS), a reproductive endocrine disorder that affects fertility in women of reproductive age, is characterized by high prevalence, diverse clinical manifestations, and unclear mechanisms. Elucidating its pathogenesis is of great significance for the treatment and prevention of PCOS. The gut microbiota, as a key modulator of human metabolism, plays a crucial role in PCOS through its interactions with the immune system. Gut microbiota and its metabolites not only serve as essential components of human metabolism but also act as critical regulators of the immune system. Therefore, this review focuses on the role of gut microbiota and the immune system in the pathogenesis of PCOS. It highlights the interactions between gut microbiota and its metabolites (such as lipopolysaccharides, branched-chain amino acids, and short-chain fatty acids) with the immune system, and their effects on key symptoms of PCOS, including inflammation, ovarian dysfunction, and insulin resistance. Furthermore, potential therapeutic strategies for alleviating PCOS are discussed, aiming to provide guidance for the treatment and prevention of PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.